ClockBase: a comprehensive platform for biological age profiling in human and mouse
Ying, K.; Tyshkovskiy, A.; Trapp, A.; Liu, H.; Moqri, M.; Kerepesi, C.; Gladyshev, V. N.
Show abstract
Decades of publicly available molecular studies have generated millions of samples testing diverse interventions, yet these datasets were rarely analyzed for their effects on aging. Aging clocks now enable biological age estimation and life outcome prediction from molecular data, creating an opportunity to systematically mine this untapped resource. We developed ClockBase Agent, a publicly accessible platform that reanalyzes millions of human and mouse methylation and RNA-seq samples by integrating them with over 40 aging clock predictions. ClockBase Agent employs specialized AI agents that autonomously generate aging-focused hypotheses, evaluate intervention effects on biological age, conduct literature reviews, and produce scientific reports across all datasets. Reanalyzing 43,602 intervention-control comparisons through multiple aging biomarkers revealed thousands of age-modifying effects missed by original investigators, including over 500 interventions that significantly reduce biological age (e.g., ouabain, KMO inhibitor, fenofibrate, and NF1 knockout). Large-scale systematic analysis reveals fundamental patterns: significantly more interventions accelerate rather than decelerate aging, disease states predominantly accelerate biological age, and loss-of-function genetic approaches systematically outperform gain-of-function strategies in decelerating aging. As validation, we show that identified interventions converge on canonical longevity pathways and with strong concordance to independent lifespan databases. We further experimentally validated ouabain, a top-scoring AI-identified candidate, demonstrating reduced frailty progression, decreased neuroinflammation, and improved cardiac function in aged mice. ClockBase Agent establishes a paradigm where specialized AI agents systematically reanalyze all prior research to identify age-modifying interventions autonomously, transforming how we extract biological insights from existing data to advance human healthspan and longevity.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.